SCHEMBL21858433

SCHEMBL21858433

Cc1nc2c(F)cccc2cc1Oc1cccc(F)c1C=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ CA14 Q9ULX7 1/20 0.32
▸ AR P10275 1/20 0.32
▸ ESR1 P03372 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21858424 0.89 ALDH1A1 (0.33) HTTALDH1A1MEN1KMT2ACA12
SCHEMBL21858430 0.86 SMN1; SMN2 (0.48) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL19472018 0.80 MAPT (0.35) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL18796118 0.78 LMNA (0.39) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL31576195 0.77 LMNA (0.33) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL19484249 0.77 LMNA (0.33) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL28630877 0.77 LMNA (0.33) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL19484248 0.77 SMN1; SMN2 (0.33) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL19484251 0.76 LMNA (0.35) HTTALDH1A1MAPTLMNAPOLB
SCHEMBL12488167 0.76 EGLN1 (0.35) HTTALDH1A1SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210378240-A1 OXETANYLPHENOXYQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2021-12-09 — — US disclosed
WO-2020079232-A1 OXETANYLPHENOXYQUINOLINES AND ANALOGUES BAYER AKTIENGESELLSCHAFT (DE) 2020-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210378240-A1 OXETANYLPHENOXYQUINOLINES AND ANALOGUES CBR3, CYP4X1, AOX1 HTT 3777/4885ALDH1A1 1754/4885MAPT 3097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback